FDA Chief Marty Makary Discusses Compounded GLP-1s, Vaccines, and Agency Challenges

FDA chief Marty Makary addresses the contentious period for the agency, marked by significant staff and budget cuts, and discusses changes to vaccine policy and the use of compounded GLP-1s.

19 Feb, 19:52 — 19 Feb, 19:52

Post Share

Sources

Showing 1 of 1 sources

cnbcMostly Factual48d ago

Healthy Returns: FDA chief Marty Makary on compounded GLP-1s, vaccines and China

Makary helms the FDA in the midst of a contentious stretch for the agency, defined by massive staff and budget cuts and sweeping changes to vaccine policy.

Read full article →

PERSPECTA

PERSPECTA

FDA Chief Marty Makary Discusses Compounded GLP-1s, Vaccines, and Agency Challenges

Sources

Healthy Returns: FDA chief Marty Makary on compounded GLP-1s, vaccines and China

Related Stories

Philippines Grapples with Persistent Unsafe Abortions Despite Ban

Supreme Court directs CBI probe into Bengaluru woman's sexual assault case

Netherlands Updates Dietary Guidelines to Promote Plant-Based Proteins

Healthcare Staff Evacuated from Gothenburg Children's Hospital Due to Illness

PERSPECTA